Counselors in Felton, DE Accepting Medicare
4 Counselors found. Showing 1 - 4
 Mrs. Betty A Carson, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5407 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-3800 Fax: 302-284-3892 |
Rebecca Webb Counselor Medicare: Not Enrolled in Medicare Practice Location: 829 Barney Jenkins Rd, Felton, DE 19943 Phone: 302-233-0657 |
Mrs. Christina B. Kane, LPCMH Counselor Medicare: Not Enrolled in Medicare Practice Location: 145 Fox Chase Rd, Felton, DE 19943 Phone: 302-335-5858 Fax: 302-335-5858 |
Cara R. Tilbury, PHD Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 75 Jubilee Ct, Felton, DE 19943 Phone: 716-870-2125 |
News Archive
Physical activity boosted cognition in breast cancer survivors, study says
A study conducted by a team of researchers at the San Diego School of Medicine, University of California, reported that physical activities can more than double the post-treatment mental processing speed of breast cancer survivors.
Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Study helps uncover how brain processes and interprets facial expressions
Research released today helps reveal how human and primate brains process and interpret facial expressions, and the role of facial mimicry in everything from deciphering an unclear smile to establishing relationships of power and status.
YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation
YM BioSciences Inc., today announced that it has received positive opinions from the Committee for Orphan Medicinal Products of the European Commission to grant Orphan Medicinal Product Designation to its JAK1/JAK2 inhibitor, CYT387, for the treatment of primary myelofibrosis, post-polycythaemia vera myelofibrosis and post-essential thrombocythaemia myelofibrosis.
› Verified 8 days ago
Psychologists
Counselors
Clinical Social Workers
Occupational Therapists
Marriage Counselors